Top compounds associated with response to AC007163.1


Feature Type Standardized
Nominal ANOVA
mRNA MK-0752 CTRPv2 pan-cancer AAC -0.00018 1
mRNA BRD-K04800985 CTRPv2 pan-cancer AAC -0.00012 1
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.00011 1
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -6.3e-05 1
Download CSV